Immune System Diseases
104
11
23
55
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
21 trials with published results (20%)
Research Maturity
55 completed trials (53% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.9%
3 terminated out of 104 trials
94.8%
+8.3% vs benchmark
10%
10 trials in Phase 3/4
38%
21 of 55 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 55 completed trials
Clinical Trials (104)
Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
HIV Engagement and Adolescent Depression Support (HEADS-UP)
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Immuno-Oncology Database and Bioregistry
Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL
Administration of T Lymphocytes for Prevention of Relapse of Lymphomas
A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D
Oral Immunotherapy in Food Allergy in Finland
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Clonal Hematopoiesis of Immunological Significance
Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation